Wordt geladen...
ONC201: a new treatment option being tested clinically for recurrent glioblastoma
Glioblastoma is an aggressive central nervous system tumor with a 5-year-survival rate of less than 10%. Patients diagnosed with the disease are treated with surgery, radiation and temozolomide chemotherapy. Despite survival benefits, patients eventually relapse. There is a need for new treatments w...
Bewaard in:
| Gepubliceerd in: | Transl Cancer Res |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6117120/ https://ncbi.nlm.nih.gov/pubmed/30175049 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tcr.2017.10.03 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|